First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. - CNBC
AI Summary1 min read
TL;DR
Novo Nordisk has launched the first GLP-1 pill for obesity in the U.S., offering a daily oral alternative to weekly injections like Wegovy, marking a significant shift in weight-loss drug options.
Tags
GLP-1 pillobesity treatmentNovo NordiskWegovyweight-loss drugs
- First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. CNBC
- What to watch for in weight loss drugs in 2026: Price changes, GLP-1 pills and more NBC News
- Starter dose of Wegovy now available as a daily pill instead of weekly injection CNN
- The expanding landscape of GLP-1 medicines Nature
- Novo launches Wegovy weight-loss pill for sale in US Reuters